Dr. Amy Susan Paller , MD
Dermatology - Pediatric Dermatology • Chicago, IL
2515 N Clark
Chicago, IL 60614
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Amy Paller is listed in NPPES under Dermatology - Pediatric Dermatology.
-
NPI assigned on March 24, 2006; this date does not establish years in practice.
-
Published CMS data list 11 Medicare Part D prescriptions, including refills, in 2022.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022. Published rows only; this is not a quality measure.
-
Published Part D records, 2022:
- Fluocinonide — 11 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 33 in 2019 to 11 in 2022.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019–2022.
Practice Location & Contact Primary Location
2515 N Clark
Chicago, IL 60614
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Chicago, IL; Northbrook, IL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Lurie Children'S Medical Group Inc.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Stanford University School Of Medicine
1978
What Public CMS Data Show
Dermatology - Pediatric Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
11 standardized 30-day fills in 2022
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$260 in 2022
The total cost of these prescriptions in 2022, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022.
Open Payments general payments, program year 2025
All general payments: $126,121.47 across 76 records.
By nature of payment (3 largest of 6)
- Consulting Fee: $80,320.90 across 22 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $24,883.00 across 10 records.
- Travel and Lodging: $10,228.03 across 13 records.
Reporting-company totals (3 largest of 16)
- Sanofi and Genzyme US Companies: $37,108.49 across 17 records.
- Eli Lilly and Company: $32,303.42 across 12 records.
- BioCryst Pharmaceuticals, Inc.: $11,122.83 across 4 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
48 years (graduated 1978)
CMS Doctors and Clinicians data list 1978 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Paller has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Paller as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chicago and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Paller are from 2022.
6 active clinicians are listed under Dermatology - Pediatric Dermatology with a practice address in Chicago, IL (10 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 67% from 33 in 2019 to 11 in 2022.
- 2019: 33
- 2020: 39
- 2021: 12
- 2022: 11
-
30-day fills
30-day fills decreased 67% from 33 in 2019 to 11 in 2022.
- 2019: 33
- 2020: 41
- 2021: 12
- 2022: 11
-
Part D drug cost
Part D drug cost decreased 99% from $19,347 in 2019 to $260 in 2022.
- 2019: $19,347
- 2020: $10,289
- 2021: $11,994
- 2022: $260
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 33% from $278,666.36 in 2021 to $187,186.42 in 2025.
- 2021: $278,666.36
- 2022: $247,495.32
- 2023: $167,511.57
- 2024: $209,934.15
- 2025: $187,186.42
Sources: CMS Medicare Part D Prescribers (2022), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 132 records totaling $187,186.42.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
General
In-kind items and services
|
RINVOQ | Research | $13,895.39 |
| Amgen Inc. |
General
Cash or cash equivalent
|
OTEZLA | Research | $13,654.66 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
EBGLYSS | General | $10,800.00 |
| Chiesi USA, Inc. |
Consulting Fee
Cash or cash equivalent
|
FILSUVEZ | General | $9,100.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $8,533.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
EBGLYSS | General | $8,100.00 |
| Sanofi and Genzyme US Companies |
Travel and Lodging
Cash or cash equivalent
|
— | General | $7,207.31 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $6,900.00 |
| BioCryst Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $5,925.00 |
| Boehringer Ingelheim International GmbH |
Consulting Fee
Cash or cash equivalent
|
— | General | $5,525.00 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $5,187.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $4,600.00 |
| BioCryst Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $4,500.00 |
| Sanofi and Genzyme US Companies |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,896.40 |
| Regeneron Pharmaceuticals, Inc. |
General
In-kind items and services
|
DUPIXENT | Research | $3,426.80 |
| Abeona Therapeutics, Inc. |
Honoraria
Cash or cash equivalent
|
ZEVASKYN | General | $3,400.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
EBGLYSS | General | $3,150.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
OLUMIANT | General | $3,150.00 |
| Abeona Therapeutics, Inc. |
Honoraria
Cash or cash equivalent
|
ZEVASKYN | General | $2,975.00 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,800.00 |
| Boehringer Ingelheim International GmbH |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,762.50 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
EBGLYSS | General | $2,700.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
OLUMIANT | General | $2,700.00 |
| Regeneron Pharmaceuticals, Inc. |
General
In-kind items and services
|
DUPIXENT | Research | $2,499.00 |
| Pfizer Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,400.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2022.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Fluocinonide | Fluocinonide | 11 | 77 | $259.57 | — |
Source: CMS Part D by Provider and Drug, 2022; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-09-01NUCC Taxonomy Code: 207NP0225X
A pediatric dermatologist has, through additional special training, developed expertise in the treatment of specific skin disease categories with emphasis on those diseases which predominate in infants, children and adolescents.
NUCC Taxonomy Code: 208000000X
A pediatrician is concerned with the physical, emotional and social health of children from birth to young adulthood. Care encompasses a broad spectrum of health services ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. A pediatrician deals with biological, social and environmental influences on the developing child, and with the impact of disease and dysfunction on development.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20041101000512
IL
1355303421
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Lurie Children's Medical Group Inc.
1131 Techny Rd, Northbrook, IL 600625503
Phone: 8005437362
Lurie Children's Medical Group Inc.
225 E Chicago Ave, Chicago, IL 606112991
Phone: 3122276415
Secondary Practice Locations
1131 Techny Rd
Northbrook, IL 600625503
Phone: 8005437362
225 E Chicago Ave
Chicago, IL 606112991
Phone: 8005437362
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 225 E CHICAGO AVE, CHICAGO, IL 606112991 (Tel: 8005437362)
Additional practice office at 225 E Chicago Ave, Chicago, IL 606112991
Additional practice office at 1131 Techny Rd, Northbrook, IL 600625503
NPI status registered as active in NPPES database
Registered at 2515 N CLARK, CHICAGO, IL 60614 (Tel: 3122276060)
Registered at BOX 107, 2300 CHILDRENS PLAZA, CHICAGO, IL 606143394 (Tel: 3122276060)
Recorded as AMY PALLER, MD
Pediatrics (license number reported to NPPES: IL 036059158)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology - Pediatric Dermatology Specialists in Chicago
Healthcare providers in ChicagoMailing Address
225 E Chicago Ave
Chicago, IL 606112991
Phone: 8005437362